Sugentech, Inc. Logo

Sugentech, Inc.

Develops advanced in-vitro diagnostic systems for hospitals, clinics, and at-home use.

253840 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
대전광역시 유성구 테크노2로 206 사무동2층 수젠텍, 대전광역시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Sugentech, Inc. is an in-vitro diagnostic (IVD) company that develops and commercializes next-generation diagnostic products by integrating biotechnology (BT), nanotechnology (NT), and information technology (IT). The company specializes in immunochemical diagnostics, leveraging its proprietary platforms for high-level antibody development and high-sensitivity immunoassay technologies. Sugentech offers a range of diagnostic systems tailored to various healthcare settings: multi-immunoblot automation systems for hospitals and medical centers, point-of-care testing (POCT) for smaller clinics, and mobile health (m-Health) solutions for personal, at-home use. Its products are designed for the diagnosis of conditions such as infectious diseases, cardiovascular diseases, and diabetes, aiming to provide personalized and accessible digital healthcare solutions.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Sugentech, Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-08 00:00
Transaction in Own Shares
자기주식처분결과보고서
Korean 35.7 KB
2025-09-08 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 6.2 KB
2025-08-29 00:00
Capital/Financing Update
주요사항보고서(교환사채권발행결정)
Korean 53.4 KB
2025-08-29 00:00
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
Korean 42.9 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.7 MB

Automate Your Workflow. Get a real-time feed of all Sugentech, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Sugentech, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Klaria Pharma Holding AB Logo
Develops oral films for non-invasive drug delivery as an alternative to injections and sprays.
Sweden KLAR
KOA SHOJI HOLDINGS CO.,LTD. Logo
Imports APIs and manufactures generic drugs for Japan's pharmaceutical industry.
Japan 9273
KOBAYASHI PHARMACEUTICAL  CO.,LTD. Logo
Manufactures OTC pharma, personal care, and household goods for niche consumer markets.
Japan 4967
Kohjin Bio Co., Ltd. Logo
A CDMO providing culture media & bioservices for cell therapy, research, and diagnostics.
Japan 177A
KOLON LIFE SCIENCE Inc. Logo
Develops gene therapies and manufactures APIs, providing global CDMO/CMO services.
South Korea 102940
Kolon TissueGene, Inc. Logo
Developing cell and gene therapies for orthopedic and degenerative disorders.
United States of America 950160
Develops animal health products and novel drugs for human cancer and autoimmune diseases.
South Korea 041960
KOREA ARLICO PHARM CO.,LTD. Logo
Manufactures generic drugs and provides CDMO services to a global market.
South Korea 260660
Develops and manufactures prescription (ETC) and over-the-counter (OTC) medicines for public health.
South Korea 014570
K Pharma,Inc. Logo
Develops iPS cell-based drugs and regenerative medicine for central nervous system disorders.
Japan 4896

Talk to a Data Expert

Have a question? We'll get back to you promptly.